Dreavent, Inc.

VC · Boston (United States)

VC

Seed

Series A

Healthcare

Sign up free to access full profile and submit your pitch.

About

Dreavent is a venture capital firm focused on the Boston biotech ecosystem, investing in emerging U.S. biopharma companies specializing in Oncology, Neurology, Cardiovascular, and Immunology.

Investment Criteria

Other investors that have backed the same portfolio companies as Dreavent, Inc.. Expand any entry to see the shared portfolio companies.

• BeAble Capital

  1 shared

  Shared portfolio companies

  • Arrays-for-cell Nanodevices S.L
• Clal Biotechnology Industries (CBI)

  1 shared

  Shared portfolio companies

  • Elicio Therapeutics, Inc.
• Clinical Research Ventures

  1 shared

  Shared portfolio companies

  • Astrocyte Pharmaceuticals Inc.
• Decheng Capital

  1 shared

  Shared portfolio companies

  • Aardvark Therapeutics, Inc.
• DeepWork Capital

  1 shared

  Shared portfolio companies

  • Astrocyte Pharmaceuticals Inc.
• Infinitas Capital Group Ltd

  1 shared

  Shared portfolio companies

  • Atai Beckley N.V.
• Leafy Tunnel

  1 shared

  Shared portfolio companies

  • Atai Beckley N.V.
• Life Science Angel

  1 shared

  Shared portfolio companies

  • Astrocyte Pharmaceuticals Inc.
• Maiora Ventures

  1 shared

  Shared portfolio companies

  • Atai Beckley N.V.
• Navis Capital Partners

  1 shared

  Shared portfolio companies

  • Astrocyte Pharmaceuticals Inc.